CYTOPREVENT Trademark

Trademark Overview


On Friday, July 15, 2022, a trademark application was filed for CYTOPREVENT with the United States Patent and Trademark Office. The USPTO has given the CYTOPREVENT trademark a serial number of 79358900. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Wednesday, December 20, 2023. This trademark is owned by VYGON SAS. The CYTOPREVENT trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Organization and conducting of non-virtual in-person educational discussion forums in the field of healthcare, toxicology, healthcare procedures, avoiding contamination risks from occupational exposure to hazardous drugs on healthcare professionals

Providing information with respect to medical matters, namely, drug use testing services, medical procedure protocols, medical safety protocols, drug dosage and use information and drug interaction information

Providing information with respect to scientific matters, namely, drug screening for scientific research purposes, toxicity and handling of cytotoxic materials
cytoprevent

General Information


Serial Number79358900
Word MarkCYTOPREVENT
Filing DateFriday, July 15, 2022
Status645 - FINAL REFUSAL - MAILED
Status DateWednesday, December 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOrganization and conducting of non-virtual in-person educational discussion forums in the field of healthcare, toxicology, healthcare procedures, avoiding contamination risks from occupational exposure to hazardous drugs on healthcare professionals
Description of MarkThe mark consists of the stylized wording "CYTOPREVENT" on a cloud-shaped design.
Goods and ServicesProviding information with respect to medical matters, namely, drug use testing services, medical procedure protocols, medical safety protocols, drug dosage and use information and drug interaction information
Goods and ServicesProviding information with respect to scientific matters, namely, drug screening for scientific research purposes, toxicity and handling of cytotoxic materials

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 3, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVYGON SAS
Party Type10 - Original Applicant
Legal Entity Type34 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Tuesday, January 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 30, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, January 7, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, May 2, 2023ASSIGNED TO EXAMINER
Thursday, May 4, 2023NON-FINAL ACTION WRITTEN
Friday, May 5, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 14, 2023REFUSAL PROCESSED BY MPU
Wednesday, June 14, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 5, 2023REFUSAL PROCESSED BY IB
Thursday, December 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 20, 2023FINAL REFUSAL WRITTEN
Wednesday, December 20, 2023FINAL REFUSAL E-MAILED
Wednesday, December 20, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 19, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, June 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB